Showing results (11-20 of 120) with videos related to
Sort By:
Pageof 12
Journal of Clinical Gastroenterology|August 1, 1987
High grade dysplasia in Crohn's colitis characterized by flow cytometryM J McKinley, D R Budman, E KahnBreast Cancer Research and Treatment|May 30, 2009
The hedgehog pathway as a therapeutic target for treatment of breast cancerM F Barginear, M Leung, D R BudmanAmerican Journal of Clinical Pathology|June 1, 1981
The diagnostic value of the serum lactic dehydrogenase determination in the evaluation of unexplained thrombocytosisD R Budman, H Lackner, P Berczeller, et al.Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase I evaluation of divided-dose vinblastine sulfateP Schulman, D R Budman, V Vinciguerra, et al.Cancer Treatment Reports|January 1, 1982
Phase I trial of spirogermanium given by infusion in a multiple-dose scheduleD R Budman, P Schulman, V Vinciguerra, et al.Critical Reviews in Oncology/Hematology|February 5, 2008
Implications of applied research for prognosis and therapy of breast cancerM F Barginear, T Bradley, I Shapira, et al.Cancer Research|February 15, 1997
Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cellsL G Wang, X M Liu, W Kreis, et al.The American Journal of Medicine|January 1, 1979
Massive lymphadenopathy mimicking lymphoma in leukemic reticuloendotheliosisD R Budman, B Koziner, Z Arlin, et al.Biochemical Pharmacology|September 14, 1999
Synergistic effect of estramustine and [3'-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cellsL G Wang, X M Liu, D R Budman, et al.Biochemical and Biophysical Research Communications|May 21, 1999
Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activityL G Wang, X M Liu, W Kreis, et al.Pageof 12